ZS vs. ABBV
ZS (Zscaler, Inc.) and ABBV (AbbVie Inc.) are both stocks. ZS operates in Software - Infrastructure (Technology), while ABBV operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, ZS returned -9.02%/yr vs 18.94%/yr for ABBV. At a 0.10 correlation, their price movements are largely independent.
Performance
ZS vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZS achieves a -42.42% return, which is significantly lower than ABBV's 1.30% return.
ZS
- 1D
- 2.70%
- 1M
- -19.58%
- YTD
- -42.42%
- 6M
- -45.18%
- 1Y
- -57.11%
- 3Y*
- -6.33%
- 5Y*
- -9.02%
- 10Y*
- —
ABBV
- 1D
- 1.32%
- 1M
- 8.24%
- YTD
- 1.30%
- 6M
- 3.65%
- 1Y
- 23.06%
- 3Y*
- 22.39%
- 5Y*
- 18.94%
- 10Y*
- 19.10%
ZS vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ZS Zscaler, Inc. | -42.42% | 24.67% | -18.57% | 98.00% | -65.18% | 60.90% | 329.48% | 18.59% | 42.58% |
ABBV AbbVie Inc. | 1.30% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -17.25% |
Correlation
The correlation between ZS and ABBV is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.00 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Mar 16, 2018 | 0.10 |
The correlation between ZS and ABBV shifts across timeframes, from -0.11 (1 year) to 0.10 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ZS:
$20.82B
ABBV:
$403.99B
ZS:
-$0.49
ABBV:
$2.05
ZS:
6.48
ABBV:
6.43
ZS:
8.80
ABBV:
14.69
ZS:
$3.17B
ABBV:
$62.82B
ZS:
$2.43B
ABBV:
$46.15B
ZS:
$69.08M
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZS vs. ABBV — Risk / Return Rank
ZS
ABBV
ZS vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zscaler, Inc. (ZS) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZS | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.89 | ||
| Sortino ratioReturn per unit of downside risk | -2.76 | ||
| Omega ratioGain probability vs. loss probability | 0.79 | 1.18 | -0.39 |
| Calmar ratioReturn relative to maximum drawdown | -0.88 | 1.29 | -2.17 |
| Martin ratioReturn relative to average drawdown | -1.55 | 2.88 | -4.42 |
Loading charts...
Drawdowns
ZS vs. ABBV - Drawdown Comparison
The maximum ZS drawdown since its inception was -76.41%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ZS and ABBV.
Loading charts...
Drawdown Indicators
| ZS | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.41% | -45.09% | -31.32% |
Max Drawdown (1Y)Largest decline over 1 year | -64.89% | -17.32% | -47.57% |
Max Drawdown (3Y)Largest decline over 3 years | -64.89% | -20.74% | -44.15% |
Max Drawdown (5Y)Largest decline over 5 years | -76.41% | -21.92% | -54.49% |
Max Drawdown (10Y)Largest decline over 10 years | — | -45.09% | — |
Current DrawdownCurrent decline from peak | -64.88% | -4.60% | -60.28% |
Average DrawdownAverage peak-to-trough decline | -32.68% | -10.71% | -21.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.90% | 7.75% | +29.15% |
Volatility
ZS vs. ABBV - Volatility Comparison
Zscaler, Inc. (ZS) has a higher volatility of 44.34% compared to AbbVie Inc. (ABBV) at 6.10%. This indicates that ZS's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZS | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 44.34% | 6.10% | +38.24% |
Volatility (6M)Calculated over the trailing 6-month period | 57.43% | 17.85% | +39.58% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.73% | 24.31% | +34.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.07% | 22.89% | +33.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.78% | 25.73% | +33.05% |
Dividends
ZS vs. ABBV - Dividend Comparison
ZS has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 2.96%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.96% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
ZS Zscaler, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ZS vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Zscaler, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ZS vs. ABBV - Profitability Comparison
ZS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Zscaler, Inc. reported a gross profit of 657.82M and revenue of 850.48M. Therefore, the gross margin over that period was 77.4%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
ZS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Zscaler, Inc. reported an operating income of -29.64M and revenue of 850.48M, resulting in an operating margin of -3.5%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
ZS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Zscaler, Inc. reported a net income of -13.88M and revenue of 850.48M, resulting in a net margin of -1.6%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
Frequently Asked Questions
ZS and ABBV have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZS has higher volatility (44.34%) compared to ABBV (6.10%). In terms of maximum drawdown, ZS dropped -76.41% vs ABBV's -45.09%.
ABBV currently has the higher Sharpe Ratio (0.92 vs -0.97), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZS and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer